# Hemp Access and Consumer Safety Act

Right now, CBD (cannabidiol) derived from hemp sits in a legal gray area. The FDA has been cracking down on companies selling hemp-derived CBD in dietary supplements and food products, treating them as unapproved drugs rather than dietary supplements. This bill would change that by officially allowing hemp-derived CBD and other hemp-derived ingredients to be sold as dietary supplements and food additives, similar to how vitamins and minerals are currently sold.

The practical effect is that it would open up the market for CBD products. If you want to buy CBD gummies, capsules, or other products marketed as dietary supplements or added to foods, this bill would make that legal and regulated rather than prohibited. Companies could sell these products more openly without fear of FDA enforcement actions. The bill also gives the FDA authority to set labeling requirements so consumers know what they're buying—for instance, requiring companies to clearly state the amount of CBD in each product and verify their claims.

For consumers, this could mean easier access to hemp-derived CBD products and more standardized information on labels so you can make informed choices. However, it's important to note that dietary supplements are less strictly regulated than prescription drugs, so the FDA wouldn't need to prove these products work before they hit store shelves. The bill essentially treats hemp-derived CBD like other dietary supplements you can buy without a prescription, which means more availability but also less guarantee of effectiveness compared to FDA-approved medications.

Hemp Access and Consumer Safety Act

Blumenauer, Earl

Hemp Access and Consumer Safety Act This bill allows hemp and hemp-derived ingredients to be included in food and dietary supplements. Current law prohibits, with limited exceptions, the sale of food and dietary supplements that contain an ingredient that is an active ingredient in (1) an approved drug, or (2) a drug for which there have been substantial and publicly known clinical investigations. This bill exempts hemp and hemp-derived ingredients, such as hemp-derived cannabidiol, from this prohibition. The Food and Drug Administration may establish labeling and packaging requirements for such foods and dietary supplements.